pamidronate has been researched along with Diabetes, Phosphate in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clarify the relations between reflex sympathetic dystrophy syndrome and moderate phosphate diabetes, we prospectively determined urinary phosphate excretion parameters (clearance, renal tubular reabsorption of phosphate and threshold of tubular reabsorption of phosphate) in 37 patients with reflex sympathetic dystrophy syndrome before and after treatment with 60 mg of pamidronate (n = 23) and in 35 age- and sex-matched controls." | 7.69 | Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate. ( Cantagrel, A; Laroche, M; Mazieres, B; Moulinier, L; Redon-Dumolard, A, 1997) |
| "To clarify the relations between reflex sympathetic dystrophy syndrome and moderate phosphate diabetes, we prospectively determined urinary phosphate excretion parameters (clearance, renal tubular reabsorption of phosphate and threshold of tubular reabsorption of phosphate) in 37 patients with reflex sympathetic dystrophy syndrome before and after treatment with 60 mg of pamidronate (n = 23) and in 35 age- and sex-matched controls." | 3.69 | Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate. ( Cantagrel, A; Laroche, M; Mazieres, B; Moulinier, L; Redon-Dumolard, A, 1997) |
| "McCune-Albright syndrome (MAS) is sometimes complicated by hypophosphatemia and abnormally low levels of 1,25(OH)(2)D in the presence of hypophosphatemia." | 1.33 | The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. ( Imanishi, Y; Inaba, M; Jüppner, H; Kinoshita, E; Koshiyama, H; Miyauchi, A; Nakagomi, Y; Nishizawa, Y; Ozono, K; Satomura, K; Shimizu, N; Yamamoto, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, T | 1 |
| Imanishi, Y | 1 |
| Kinoshita, E | 1 |
| Nakagomi, Y | 1 |
| Shimizu, N | 1 |
| Miyauchi, A | 1 |
| Satomura, K | 1 |
| Koshiyama, H | 1 |
| Inaba, M | 1 |
| Nishizawa, Y | 1 |
| Jüppner, H | 1 |
| Ozono, K | 1 |
| Laroche, M | 1 |
| Redon-Dumolard, A | 1 |
| Moulinier, L | 1 |
| Cantagrel, A | 1 |
| Mazieres, B | 1 |
2 other studies available for pamidronate and Diabetes, Phosphate
| Article | Year |
|---|---|
The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
Topics: Adolescent; Adult; Calcium; Child; Diphosphonates; Female; Fibroblast Growth Factor-23; Fibroblast G | 2005 |
Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate.
Topics: Adult; Aged; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypophosphatemia, Fami | 1997 |